L

Liquidia

Clinical-stage biopharma developing PRINT-based therapeutics

Key Account Director

Field SalesPosted on Nov 11
Full-timeRemote in USANo salary listed

About the Job

Requirements

  • A Bachelor of Science degree or equivalent.
  • Prior pulmonary arterial hypertension (PAH) or pulmonary hypertension-associated interstitial lung disease (PHILD) experience and existing key opinion leader (KOL) relationships.
  • A minimum of five years of pulmonary hypertension therapeutic area experience.
  • At least five years of work experience in one or more of marketing, clinical liaison, thought leader management, key account management, market access, or clinical sales.
  • A proven track record of consistently achieving or exceeding expectations in assigned responsibilities.
  • Ability to build credibility and trust with KOLs.
  • A strategic mindset, including anticipating and interpreting KOL beliefs to identify opportunities to support commercial and marketing strategy, messaging, and resources.
  • Ability to build trusted relationships with cross-functional partners.
  • Deep knowledge of academic medical centers, including referral patterns and networks.
  • Excellent verbal and written communication skills and the ability to present to large and small audiences.
  • Excellent product and pulmonary hypertension disease-state knowledge.
  • Ability to take initiative and lead through change, ambiguity, and complexity.
  • Strong understanding of the laws, regulations, and rules governing the pharmaceutical industry, and a history of ethical and compliant behavior.
  • Exceptional organizational skills.
  • Ability to travel 60%–80%.

Responsibilities

  • Identify, develop, and maintain professional relationships with national and regional pulmonary hypertension centers and KOLs.
  • Generate business insights and explore engagement opportunities, including advisory boards, speaker bureaus, congresses and regional symposiums, and sales training.
  • Identify and develop KOLs for regional and national-level engagement.
  • Partner compliantly and ethically with Medical Affairs on complementary strategic initiatives involving shared KOLs.
  • Lead regional direct marketing efforts and tactics with targeted accounts and KOLs.
  • Gather and provide KOL insights about current treatment-management patterns and future treatments to inform commercial and marketing strategy, initiatives, and resources.
  • Partner with the commercial sales team to identify key accounts, thought leaders, issues, and trends in geographic areas.
  • Act as a liaison between KOLs and Liquidia, connecting them with cross-functional partners and other healthcare professionals.
  • Develop and execute strategies for KOL congress participation and supporting development.
  • Lead the development and delivery of regional speaker programs, including developing and training speakers, developing content, and attending programs.
  • Assist compliantly in planning Liquidia marketing advisory boards through advisor identification and meeting-objective development.
  • Collaborate with cross-functional partners to provide access and reimbursement support and education at regional accounts.
  • Establish and maintain regional relationships between specialty pharmacy field team members in collaboration with the market access team.
  • Understand the payer reimbursement landscape and support communication of the brand's market access value positioning.
  • Identify and troubleshoot specific brand access issues and leverage resources to work toward resolutions.
  • Operate in alignment with Liquidia's code of ethics and compliance standard operating procedures, ensuring KOL interactions comply with commercial, regulatory, and legal guidelines.

About the Company

Liquidia

Clinical-stage biopharma developing PRINT-based therapeutics

Liquidia uses PRINT particle engineering to design drug particles that can improve safety, efficacy, and manufacturability. Its two main candidates are LIQ861 for pulmonary arterial hypertension and LIQ865 for local post-operative pain, developed through clinical testing toward commercialization. The technology controls particle size and properties to enhance delivery and performance while aiming to reduce production complexity and cost. By tailoring particle delivery for specific conditions, Liquidia pursues regulatory approvals to bring products to market and generates revenue from sales, supported by stock offerings for funding.

Company size
201-500
Company stage
IPO
Headquarters
Morrisville, NC
Founded
2004

Recently Posted Jobs

Explore more opportunities at Liquidia

See more jobs